Mikael Herlevsen Email

Director, IP . Rivus Pharmaceuticals

Current Roles

Employees:
15
Revenue:
$1.2M
About
Rivus Pharmaceuticals, Inc., is dedicated to transforming the treatment of cardio-metabolic disease by advancing a new class of oral, once daily, small molecule therapeutics called Controlled Metabolic Accelerators (CMAs). Rivus’ CMAs are designed to improve cellular metabolism and treat the underlying cause of highly prevalent metabolic and cardiovascular diseases including type 2 diabetes, severe hypertriglyceridemia (SHTG), non-alcoholic steatohepatitis (NASH), as well as cardiovascular diseases such as heart failure with reduced ejection fraction (HFpEF). For more information please visit https://www.rivuspharma.com/
Rivus Pharmaceuticals Address
706 B Forest Street
null, null
Rivus Pharmaceuticals Email

Past Companies

Rivus PharmaceuticalsDirector, IP
Gencia CorporationDirector, IP
University of Virginia Patent FoundationLicensing Associate

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.